Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
Victoria Y Ling1,2, Denise Lee1, Zoe Mcquilten3
1Malignant Haematology & Stem Cell Transplantation Unit, Department of Clinical Haematology, Alfred Health, Melbourne, Australia.
American Journal of Hematology
|August 29, 2015
Abstract
No abstract available in PubMed .
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
31.0K
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.7K
